Home

Baston Dependenta de combina antithrombotic therapy in af patients presenting with acs europace clădire Fizică umbrit

Acute management of revascularization or ACS in AF patients treated... |  Download Scientific Diagram
Acute management of revascularization or ACS in AF patients treated... | Download Scientific Diagram

Frontiers | The Management of Combined Antithrombotic Therapy in Patients  With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A  Particularly Complex Challenge, Especially in the Elderly
Frontiers | The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly

PDF] Management of antithrombotic therapy in atrial fibrillation patients  presenting with acute coronary syndrome and/or undergoing percutaneous  coronary or valve interventions: a joint consensus document of the European  Society of Cardiology Working
PDF] Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working

Management of Antithrombotic Therapy in Atrial Fibrillation Patients  Undergoing PCI: JACC State-of-the-Art Review | Journal of the American  College of Cardiology
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review | Journal of the American College of Cardiology

2021 Focused update of the 2017 consensus guidelines of the Asia Pacific  Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation -  Chao - 2021 - Journal of Arrhythmia - Wiley Online Library
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library

JCM | Free Full-Text | Antithrombotic Strategies in Patients with Atrial  Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary  Intervention
JCM | Free Full-Text | Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm  Control Therapy - ScienceDirect
Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy - ScienceDirect

Changes of antithrombotic prescription in atrial fibrillation patients with acute  coronary syndrome or percutaneous coronary intervention and the subsequent  impact on long-term outcomes: a longitudinal cohort study | Thrombosis  Journal | Full
Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudinal cohort study | Thrombosis Journal | Full

Bleeding Complications in Patients Undergoing Percutaneous Coronary  Intervention
Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention

The antithrombotic therapy of atrial fibrillation in patients with coronary  heart disease | Russian Open Medical Journal
The antithrombotic therapy of atrial fibrillation in patients with coronary heart disease | Russian Open Medical Journal

Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet  tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation  (APPROACH-ACS-AF): Rationale and design of the prospective randomized  parallel-group, open-label, blinded ...
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group, open-label, blinded ...

PDF) Great Debate: Triple antithrombotic therapy in patients with atrial  fibrillation undergoing coronary stenting should be limited to 1 week
PDF) Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week

Frontiers | Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation  Subjects After Percutaneous Coronary Intervention
Frontiers | Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention

Triple therapy in patients with atrial fibrillation and acute coronary  syndrome or percutaneous coronary intervention/stenting - Kozieł - 2020 -  Research and Practice in Thrombosis and Haemostasis - Wiley Online Library
Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting - Kozieł - 2020 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library

De-escalation of antiplatelet therapy in patients with coronary artery  disease: Time to change our strategy? - European Journal of Internal  Medicine
De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy? - European Journal of Internal Medicine

PDF] Management of antithrombotic therapy in atrial fibrillation patients  presenting with acute coronary syndrome and/or undergoing percutaneous  coronary or valve interventions: a joint consensus document of the European  Society of Cardiology Working
PDF] Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With  Oral Anticoagulation Undergoing Percutaneous Coronary Intervention |  Circulation
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation

Management of Antithrombotic Therapy in Atrial Fibrillation Patients  Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect

Antiplatelet therapy after percutaneous coronary intervention -  EuroIntervention
Antiplatelet therapy after percutaneous coronary intervention - EuroIntervention

ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline  Comparison | Journal of the American College of Cardiology
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison | Journal of the American College of Cardiology

JCM | Free Full-Text | Antithrombotic Strategies in Patients with Atrial  Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary  Intervention
JCM | Free Full-Text | Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Antithrombotic management of patients with acute coronary syndrome and atrial  fibrillation undergoing coronary stenting: a prospective, observational,  nationwide study | BMJ Open
Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study | BMJ Open

JCM | Free Full-Text | Antithrombotic Therapy for Percutaneous  Cardiovascular Interventions: From Coronary Artery Disease to Structural  Heart Interventions
JCM | Free Full-Text | Antithrombotic Therapy for Percutaneous Cardiovascular Interventions: From Coronary Artery Disease to Structural Heart Interventions

Antiplatelet therapy after percutaneous coronary intervention -  EuroIntervention
Antiplatelet therapy after percutaneous coronary intervention - EuroIntervention